Page last updated: 2024-08-21

erythromycin and moxifloxacin

erythromycin has been researched along with moxifloxacin in 69 studies

Research

Studies (69)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (5.80)	18.2507
2000's	31 (44.93)	29.6817
2010's	29 (42.03)	24.3611
2020's	5 (7.25)	2.80

Authors

Authors	Studies
Jolivette, LJ; Ward, KW	1
Jolivette, LJ; Nagilla, R; Ward, KW	1
Cars, O; Karlsson, MO; Löwdin, E; Nielsen, EI; Sandström, M; Viberg, A	1
Duewelhenke, N; Eysel, P; Krut, O	1
Chang, CL; Jeong, J; Jeong, SH; Jung, HJ; Kim, HR; Kim, S; Lee, EY; Lee, JN; Shin, JH	1
Arakawa, Y; Kato, H; Kimura, K; Konda, T; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K	1
Ardanuy, C; Bouza, E; Calatayud, L; Cercenado, E; Fenoll, A; Liñares, J; Martín, R; Pallares, R	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Calvet, L; Devine, R; Dubreuil, L; Jean-Pierre, H; Jumas-Bilak, E; Marchandin, H; Mercier, G; Morio, F	1
Brémont, S; Courvalin, P; Damier-Piolle, L; Lambert, T; Magnet, S	1
Chang, KY; Ho, YH; Hsieh, YC; Hsueh, PR; Huang, LM; Huang, YC; Lin, HC	1
Lombardo, F; Obach, RS; Waters, NJ	1
Crabb, DM; Duffy, LB; Waites, KB	1
del Pozo, JL; Mandrekar, JN; Patel, R; Rouse, MS; Sampedro, MF; Steckelberg, JM	1
Bohnert, JA; Fähnrich, E; Kern, WV; Schuster, S; Wehmeier, C	1
Li, W; Liu, Y; Wang, M; Xu, X; Ye, X; Zhang, H; Zhu, D	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Appelbaum, PC; Beachel, L; Clark, C; Dewasse, B; Kosowska-Shick, KM; McGhee, P; Nagai, K	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A	1
Cai, L; Gilbert, GL; Kong, F; Oftadeh, S; Xiao, M; Xu, X; Zhou, F	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Amsler, KM; Bush, K; Foleno, BD; He, W; Lynch, AS; Macielag, MJ; Morrow, BJ	1
Bajaksouzian, S; Biek, D; Critchley, IA; Good, CE; Jacobs, MR; Jones, RN; Sader, HS; Windau, AR	1
Ardanuy, C; Brito-Avô, A; Gonçalo-Marques, J; Liñares, J; Morais, A; Pires, R; Rolo, D; Santos-Sanches, I	1
Bishai, WR; Grosset, JH; Nuermberger, EL; Zhang, T	1
Baek, SY; Chae, SE; Cho, YL; Jeong, JW; Jung, SJ; Kim, YZ; Kwak, JH; Lee, HH; Lee, HS; Park, TK; Woo, SH	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG	1
Hammerschlag, MR; Roblin, PM	1
Eliopoulos, GM; Souli, M; Wennersten, CB	1
Dalhoff, A; Ruckdeschel, G	1
Ballin, I; Bassaris, HP; Deppermann, KM; Kubin, R; Leophonte, P; Schreurs, AJ; Sommerauer, B; Torres, A; Wilson, R	1
Betriu, C; Boloix, A; Culebras, E; Gómez, M; Palau, ML; Picazo, JJ; Redondo, M; Sánchez, A	1
Esposito, S; Ianniello, F; Noviello, S	1
Cox, BF; Gintant, GA; Limberis, JT; McDermott, JS; Wegner, CD	1
Cartwright, FD; Kenny, GE	1
Blandino, G; Caccamo, F; Milazzo, I; Musumeci, R; Nicoletti, G; Speciale, A	1
Picazo, JJ; Rodríguez-Avial, C; Rodríguez-Avial, I	1
Eisenblätter, M; Hahn, H; Ignatius, R; Jabbusch, M; Wagner, J; Wendt, C	1
Dower, SK; Moore, LJ; Pridmore, AC; Read, RC	1
Alhaddad, N; Bishop, L; Cavendish, S; Duckworth, G; George, RC; Johnson, AP; Lamagni, TL; Livermore, DM; Wale, M; Warner, M	1
Cars, O; Löwdin, E; Tano, E	1
Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP	1
Bauer, TT; Petermann, W; Reimnitz, P; Schürmann, D; Welte, T	1
Crimin, K; Engtrakul, J; Fermini, B; Fossa, AA; O'Donnell, J; Wisialowski, T	1
Bhadresa, S; Coon, DJ; Lawrence, MS; Magiera, D; Struharik, M; Ward, KW	1
Banaszkiewicz, A; Młynarczyk, G; Obuch-Woszczatyński, P; Pituch, H; Radzikowski, A; Wultańska, D	1
Ackermann, G; Christner, M; Ilchmann, C; Rohde, H; Speicher, A; Zaiss, NH	1
Cars, O; Friberg, LE; Nielsen, EI	2
Barbanti, F; Mastrantonio, P; Spigaglia, P	2
Dan, M; Rosenberg, S; Samra, Z	1
Bharathi, N; Muruganathan, G; Nair, DK; Ravi, TK	1
Borgmann, S; Gruber, H; Hensgens, MP; Jakobiak, T; Kist, M; Kuijper, EJ; Reil, M	1
Achiraman, S; Anandhakumar, S; Antony, JJ; Raichur, AM; Siva, D; Sripriya, J	1
Herath, SC; Poole, P	1
Abratt, V; Kullin, B; Reid, SJ; Wojno, J	1
Barbanti, F; Spigaglia, P	1
Crabb, DM; Duffy, LB; Jensen, JS; Liu, Y; Paukner, S; Waites, KB	1
Chen, YB; Fang, YH; Gu, SL; Li, LJ; Lv, T; Shen, P; Tang, LL	1
Herath, SC; Maisey, S; Normansell, R; Poole, P	1
Chen, A; Jabbour, S; Shekhawat, NS; Woreta, FA	1
Jane, F; Jon J, V; Mark H, W	1
Bhamare, P; Dunman, PM; Johnson, W; Kinn, B; Laskey, E; Mei, JA; Nolin, L; Stalker, C; Wozniak, RAF	1
Akpolat, N; Arabaci, C; Ay Altintop, Y; Aydemir, SS; Aydin, F; Bayramoglu, G; Birinci, A; Cekin, Y; Ceyhan, M; Gulay, Z; Gultekin, M; Gurler, N; Hascelik, G; Ozakin, C; Ozhak Baysan, B; Ozturk, C; Sanal, L; Sancak, B; Soyletir, G; Yaman, A; Zer, Y	1
Chai, X; Sun, H; Wei, S; Xu, G	1

Reviews

3 review(s) available for erythromycin and moxifloxacin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD). The Cochrane database of systematic reviews, 2013, Nov-28, Issue:11 Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Disease Progression; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic	2013
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD). The Cochrane database of systematic reviews, 2018, 10-30, Volume: 10 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Disease Progression; Drug Administration Schedule; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic; Roxithromycin; Trimethoprim, Sulfamethoxazole Drug Combination	2018

Trials

2 trial(s) available for erythromycin and moxifloxacin

Article	Year
Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis. The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:4 Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Bronchitis; Double-Blind Method; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines	1999
Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Dec-15, Volume: 41, Issue:12 Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Aza Compounds; Ceftriaxone; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Hospitalization; Humans; Injections, Intravenous; Male; Moxifloxacin; Parenteral Nutrition; Pneumonia, Bacterial; Prospective Studies; Quinolines; Remission Induction; Time Factors	2005

Article

Year

Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis.

The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:4

Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Bronchitis; Double-Blind Method; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines

1999

Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Dec-15, Volume: 41, Issue:12

Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Aza Compounds; Ceftriaxone; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Hospitalization; Humans; Injections, Intravenous; Male; Moxifloxacin; Parenteral Nutrition; Pneumonia, Bacterial; Prospective Studies; Quinolines; Remission Induction; Time Factors

2005

Other Studies

64 other study(ies) available for erythromycin and moxifloxacin

Article	Year
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure. Journal of pharmaceutical sciences, 2005, Volume: 94, Issue:7 Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution	2005
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human. Xenobiotica; the fate of foreign compounds in biological systems, 2005, Volume: 35, Issue:2 Topics: Administration, Oral; Animals; Area Under Curve; Dogs; Haplorhini; Humans; Models, Statistical; Rats; Software; Species Specificity; Xenobiotics	2005
Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1 Topics: Algorithms; Anti-Bacterial Agents; Aza Compounds; Cefuroxime; Dose-Response Relationship, Drug; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Penicillin G; Quinolines; Streptococcus pyogenes; Vancomycin	2007
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1 Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors	2007
Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7 Topics: Anti-Bacterial Agents; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Hospitals; Humans; Korea; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Ofloxacin; Pneumococcal Infections; Polymerase Chain Reaction; Prevalence; Reserpine; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae	2007
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9 Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Malates; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Uncoupling Agents	2007
Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9 Topics: Anti-Bacterial Agents; Clone Cells; Drug Resistance, Multiple, Bacterial; Electrophoresis, Polyacrylamide Gel; Erythromycin; Genes, Bacterial; Microbial Sensitivity Tests; Phenotype; Pneumococcal Infections; Serotyping; Spain; Streptococcus pneumoniae; Tetracycline Resistance	2007
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Antimicrobial susceptibilities and clinical sources of Dialister species. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity; Veillonellaceae	2007
AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Multigene Family; Sequence Analysis, DNA; Substrate Specificity	2008
Clonal spread of highly beta-lactam-resistant Streptococcus pneumoniae isolates in Taiwan. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Genotype; Humans; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; Taiwan	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10 Topics: Aminopyridines; Anti-Bacterial Agents; Fluoroquinolones; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma fermentans; Mycoplasma genitalium; Mycoplasma hominis; Mycoplasma Infections; Mycoplasma pneumoniae; Ureaplasma; Ureaplasma Infections	2008
Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1 Topics: Anti-Infective Agents; Biofilms; Bioreactors; Electricity; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis	2009
Site-directed mutagenesis reveals amino acid residues in the Escherichia coli RND efflux pump AcrB that confer macrolide resistance. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1 Topics: Amino Acid Sequence; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Macrolides; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Mutagenesis, Site-Directed; Sequence Homology, Amino Acid	2009
Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5 Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Child; China; Drug Resistance, Bacterial; Genes, rRNA; Humans; Macrolides; Microbial Sensitivity Tests; Mutation; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Respiratory Tract Infections; RNA, Ribosomal, 23S; Sequence Analysis, DNA	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Macrolides; Microbial Sensitivity Tests; Penicillin G; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles	2010
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline	2010
Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; Child, Preschool; DNA Transposable Elements; Drug Resistance, Bacterial; Erythromycin; Genotype; Humans; Macrolides; Microbial Sensitivity Tests; New South Wales; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Design; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Methicillin-Resistant Staphylococcus aureus; Streptococcus pneumoniae	2010
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; United States	2010
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Amino Acid Substitution; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; Carrier Proteins; Child; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Molecular Epidemiology; Norfloxacin; Point Mutation; Portugal; Streptococcal Infections; Streptococcus pyogenes	2010
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7 Topics: Anti-Bacterial Agents; Erythromycin; Luminescent Proteins; Microbial Sensitivity Tests; Models, Genetic; Mycobacterium ulcerans; Reserpine; Tetracycline	2010
In vitro and in vivo activities of LCB01-0371, a new oxazolidinone. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Infections; Gram-Positive Bacteria; Linezolid; Male; Mice; Mice, Inbred ICR; Oxazolidinones; Staphylococcus aureus; Vancomycin	2010
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline. Journal of medicinal chemistry, 2017, 05-11, Volume: 60, Issue:9 Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin	2017
In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Chlamydia Infections; Chlamydophila pneumoniae; Doxycycline; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Quinolones	1998
In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens. International journal of antimicrobial agents, 1998, Volume: 10, Issue:1 Topics: Amoxicillin; Anti-Infective Agents; Aza Compounds; Cefuroxime; Clavulanic Acid; Erythromycin; Fluoroquinolones; Methicillin Resistance; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Penicillin Resistance; Quinolines; Quinolones; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae; Streptococcus pyogenes	1998
The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results. The Journal of antimicrobial chemotherapy, 1999, Volume: 43 Suppl B Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Aza Compounds; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Legionella; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rifampin	1999
Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:7 Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Oxazoles; Oxazolidinones; Quinolines; Streptococcus; Virginiamycin	2000
Bactericidal activity of moxifloxacin compared to grepafloxacin and clarithromycin against Streptococcus pneumoniae and Streptococcus pyogenes investigated using an in vitro pharmacodynamic model. Journal of chemotherapy (Florence, Italy), 2000, Volume: 12, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Clarithromycin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Penicillin Resistance; Piperazines; Quinolines; Streptococcus pneumoniae; Streptococcus pyogenes; Time Factors	2000
The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis. Journal of cardiovascular pharmacology, 2001, Volume: 37, Issue:5 Topics: Action Potentials; Animals; Anti-Infective Agents; Arrhythmias, Cardiac; Aza Compounds; Cisapride; Dogs; Erythromycin; Female; Fluoroquinolones; Imidazoles; In Vitro Techniques; Indoles; Long QT Syndrome; Male; Models, Biological; Moxifloxacin; Perfusion; Piperazines; Purkinje Fibers; Quinolines; Sotalol; Swine; Torsades de Pointes	2001
Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:9 Topics: 4-Quinolones; Acetamides; Aminoglycosides; Anti-Bacterial Agents; Aza Compounds; Erythromycin; Fluoroquinolones; Gatifloxacin; Humans; Hydrogen-Ion Concentration; Ketolides; Linezolid; Macrolides; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mycoplasma hominis; Mycoplasma pneumoniae; Oxazolidinones; Quinolines; Tetracyclines; Tigecycline; Ureaplasma urealyticum; Virginiamycin	2001
Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates. International journal of antimicrobial agents, 2002, Volume: 19, Issue:2 Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma; Quinolines; Streptococcus; Teicoplanin; Thienamycins; Vancomycin	2002
[In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2001, Volume: 14, Issue:4 Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Drug Resistance; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Norfloxacin; Ofloxacin; Penicillins; Quinolines; Streptococcal Infections; Streptococcus	2001
Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Campylobacter jejuni; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Germany; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Tetracycline	2003
Penicillin enhances the toll-like receptor 2-mediated proinflammatory activity of Streptococcus pneumoniae. The Journal of infectious diseases, 2003, Oct-01, Volume: 188, Issue:7 Topics: Anti-Infective Agents; Aza Compounds; Choline; Colony Count, Microbial; Enzyme Inhibitors; Erythromycin; Ethanolamine; Fluoroquinolones; HeLa Cells; Humans; Interleukin-8; Membrane Glycoproteins; Moxifloxacin; N-Acetylmuramoyl-L-alanine Amidase; Penicillins; Pneumococcal Infections; Quinolines; Receptors, Cell Surface; Streptococcus pneumoniae; Toll-Like Receptor 2; Toll-Like Receptors; Transfection	2003
Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003. International journal of antimicrobial agents, 2005, Volume: 25, Issue:6 Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; England; Erythromycin; Fluoroquinolones; Humans; Inpatients; Microbial Sensitivity Tests; Moxifloxacin; Penicillins; Quinolines; Streptococcus pneumoniae	2005
Pharmacodynamic studies of moxifloxacin and erythromycin against intracellular Legionella pneumophila in an in vitro kinetic model. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:1 Topics: Aza Compounds; Cell Line; Erythromycin; Fluoroquinolones; Humans; Kinetics; Legionella pneumophila; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Quinolines	2005
Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:1 Topics: Anti-Bacterial Agents; Aza Compounds; Dose-Response Relationship, Drug; Erythromycin; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Humans; Legionella; Legionella pneumophila; Levofloxacin; Microbial Sensitivity Tests; Monocytes; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines	2005
Differentiation of arrhythmia risk of the antibacterials moxifloxacin, erythromycin, and telithromycin based on analysis of monophasic action potential duration alternans and cardiac instability. The Journal of pharmacology and experimental therapeutics, 2006, Volume: 318, Issue:1 Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Aza Compounds; Cell Line; Dose-Response Relationship, Drug; Erythromycin; Ether-A-Go-Go Potassium Channels; Fluoroquinolones; Guinea Pigs; Heart Rate; Humans; Ketolides; Moxifloxacin; Quinolines; Risk Factors; Torsades de Pointes	2006
Exploration of the African green monkey as a preclinical pharmacokinetic model: oral pharmacokinetic parameters and drug-drug interactions. Xenobiotica; the fate of foreign compounds in biological systems, 2009, Volume: 39, Issue:3 Topics: Animals; Aza Compounds; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Evaluation, Preclinical; Erythromycin; Fluoroquinolones; Lidocaine; Mass Spectrometry; Models, Animal; Moxifloxacin; Pharmacokinetics; Phenytoin; Prednisolone; Propranolol; Quinolines; Species Specificity	2009
[Prevalence of Clostridium difficile in the gastrointestinal tract of hospitalized children under two years of age]. Medycyna doswiadczalna i mikrobiologia, 2010, Volume: 62, Issue:1 Topics: Aza Compounds; Ciprofloxacin; Clindamycin; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Female; Fluoroquinolones; Gastrointestinal Tract; Gatifloxacin; Genotype; Humans; Infant; Infant, Newborn; Male; Metronidazole; Moxifloxacin; Phenotype; Quinolines; Species Specificity; Vancomycin	2010
Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:12 Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Bacterial Typing Techniques; Clostridioides difficile; Cross Infection; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Erythromycin; Fluoroquinolones; Germany; Hospitals, University; Humans; Microbial Sensitivity Tests; Moxifloxacin; Polymerase Chain Reaction; Prevalence; Quinolines; Ribotyping	2010
Predicting in vitro antibacterial efficacy across experimental designs with a semimechanistic pharmacokinetic-pharmacodynamic model. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4 Topics: Anti-Bacterial Agents; Aza Compounds; Cefuroxime; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Penicillin G; Quinolines; Streptococcus pyogenes; Vancomycin	2011
Surface layer protein A variant of Clostridium difficile PCR-ribotype 027. Emerging infectious diseases, 2011, Volume: 17, Issue:2 Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Canada; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Epidemics; Erythromycin; Europe; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Phylogeny; Polymerase Chain Reaction; Quinolines; Ribotyping; Sequence Analysis, DNA; Virulence	2011
Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin. Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:2 Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Doxycycline; Erythromycin; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Reproducibility of Results; Roxithromycin; Tetracycline; Time Factors; Ureaplasma Infections; Ureaplasma urealyticum	2011
Interaction study of moxifloxacin and lomefloxacin with co-administered drugs. Pakistan journal of pharmaceutical sciences, 2011, Volume: 24, Issue:3 Topics: Aluminum Hydroxide; Anti-Infective Agents; Aza Compounds; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Erythromycin; Fluoroquinolones; Hydrogen-Ion Concentration; In Vitro Techniques; Magnesium Hydroxide; Minerals; Moxifloxacin; Quinolines; Silicic Acid; Solubility; Sucralfate; Tablets; Temperature	2011
Multidrug resistance in European Clostridium difficile clinical isolates. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:10 Topics: Anti-Bacterial Agents; Aza Compounds; Clindamycin; Clostridioides difficile; Clostridium Infections; DNA Transposable Elements; DNA, Ribosomal; Drug Resistance, Multiple, Bacterial; Erythromycin; Europe; Fluoroquinolones; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Moxifloxacin; Quinolines; Ribosomal Proteins; Rifampin; RNA, Ribosomal, 23S; Tetracycline	2011
Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10 Topics: Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Cefuroxime; Computer Simulation; Erythromycin; Escherichia coli; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Moxifloxacin; Penicillin G; Quinolines; Streptococcus pyogenes; Vancomycin	2011
Seasonality of Clostridium difficile infections in Southern Germany. Epidemiology and infection, 2012, Volume: 140, Issue:10 Topics: Anti-Bacterial Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cluster Analysis; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genotype; Germany; Humans; Moxifloxacin; Quinolines; Ribotyping; Seasons	2012
Laser receptive polyelectrolyte thin films doped with biosynthesized silver nanoparticles for antibacterial coatings and drug delivery applications. International journal of pharmaceutics, 2013, Nov-30, Volume: 457, Issue:1 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bacteria; Dextran Sulfate; Drug Delivery Systems; Erythromycin; Fluoroquinolones; Lasers; Metal Nanoparticles; Moxifloxacin; Plant Extracts; Plant Leaves; Polyamines; Quinolines; Silver; Violaceae	2013
Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017, Volume: 36, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Diarrhea; Disk Diffusion Antimicrobial Tests; Enterotoxins; Erythromycin; Female; Fluoroquinolones; Hospitals, Chronic Disease; Humans; Infant; Infant, Newborn; Male; Middle Aged; Minisatellite Repeats; Molecular Epidemiology; Moxifloxacin; Ribotyping; Rifampin; South Africa; Young Adult	2017
Characterization of Clostridium difficile PCR-ribotype 018: A problematic emerging type. Anaerobe, 2016, Volume: 42 Topics: Anti-Bacterial Agents; Antibiosis; Bacterial Adhesion; Bacterial Toxins; Caco-2 Cells; Clindamycin; Clostridioides difficile; Cross Infection; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Erythromycin; Fluoroquinolones; Hospitals; Humans; Italy; Moxifloxacin; Ribotyping; Rifampin; Virulence	2016
In Vitro Activities of Lefamulin and Other Antimicrobial Agents against Macrolide-Susceptible and Macrolide-Resistant Mycoplasma pneumoniae from the United States, Europe, and China. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:2 Topics: Anti-Bacterial Agents; Azithromycin; China; Diterpenes; Doxycycline; Drug Resistance, Bacterial; Erythromycin; Europe; Fluoroquinolones; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma pneumoniae; Pleuromutilins; Polycyclic Compounds; United States	2017
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from hospitals during a 4-year period in China. Journal of medical microbiology, 2018, Volume: 67, Issue:1 Topics: Anti-Infective Agents; Bacterial Proteins; China; Clindamycin; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Moxifloxacin; Tertiary Care Centers; Vancomycin	2018
Presumed Herpes Zoster Ophthalmicus Reactivation Following Recombinant Zoster Vaccination. Cornea, 2021, Feb-01, Volume: 40, Issue:2 Topics: Aged; Anti-Bacterial Agents; Antiviral Agents; Drug Therapy, Combination; Erythromycin; Eye Infections, Viral; Female; Herpes Zoster Ophthalmicus; Herpes Zoster Vaccine; Herpesvirus 3, Human; Humans; Immunization, Secondary; Latent Infection; Moxifloxacin; Vaccination; Valacyclovir; Virus Activation; Visual Acuity	2021
Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities. Anaerobe, 2021, Volume: 70 Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Erythromycin; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; United Kingdom; Vancomycin	2021
Antimicrobial Activity of a Triple Antibiotic Combination Toward Ocular Pseudomonas aeruginosa Clinical Isolates. Translational vision science & technology, 2022, 05-02, Volume: 11, Issue:5 Topics: Anti-Bacterial Agents; Bacitracin; Drug Combinations; Erythromycin; Framycetin; Humans; Keratitis; Levofloxacin; Moxifloxacin; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Tobramycin; Trimethoprim	2022
Serotype distribution of Annals of medicine, 2023, Volume: 55, Issue:1 Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Humans; Infant; Moxifloxacin; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; Serogroup; Streptococcus pneumoniae; Turkey	2023
The Formation and Drug Resistance Mechanism of Biofilm for Streptococcus pneumoniae Infection in Severe Respiratory Patients. Cellular and molecular biology (Noisy-le-Grand, France), 2023, Jan-31, Volume: 69, Issue:1 Topics: Anti-Bacterial Agents; DNA Topoisomerase IV; Drug Resistance; Drug Resistance, Bacterial; Erythromycin; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae	2023